OHSU researchers define molecular basis to explain link between a pregnant mother’s nutrition and infant growth. In a study published online in Nature Communications, a research team led by...
Diabetes affects nearly 30 million people in the United States. The disease is caused by dysfunction or loss of insulin-producing beta cells that normalize blood sugar levels in the body. Until now,...
Gene therapy offers great promise for treating genetic disorders and in repairing or correcting injury and disease. However, efforts to modify and expand the pool of gene-edited cells to reach...
At OHSU, the passion we bring to our work leads to discoveries, educational opportunities, and patient successes that literally change the world. At the heart of our success are faculty members that...
David Lewinsohn, M.D., Ph.D., in the Papé Family Pediatric Research Institute at OHSU Doernbecher Children's Hospital, has been awarded a $3 million grant from the Bill & Melinda Gates...
The OHSU Gene Therapy Working Group and the Pape’ Family Pediatric Research Institute invite you to attend the 4th Annual Gene Therapy Symposium, an afternoon event to showcase OHSU’s Gene...
Gene therapy, a promising clinical approach to treat patients with a range of inherited diseases, often uses vectors derived from lentiviruses to insert a correcting genetic sequence into the...
The Basic & Translational Sciences Seminar Series, co-sponsored by the Knight Cancer Institute and the Department of Cell & Developmental Biology, provides an emphasis on fundamental science...
The OHSU Gene Therapy Working Group and the Rare Disorders Research Consortium invite you to attend the 2nd Annual Gene Therapy Symposium, an afternoon event to showcase OHSU’s Gene Therapy...
"Liver stem cell therapy for humans is coming," said Markus Grompe, M.D., director of the Papé Family Pediatric Research Institute and co-author of a new Nature paper that describes how a...